Clinical Trials Browser

Not yet recruiting × Gastric / Gastroesophageal Junction Adenocarcinoma × 1 year × Clear all

NCT07149181 2025-08-29

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery

Phase 4 Not yet recruiting

Gastrointestinal

Gastric / Gastroesophageal Junction Adenocarcinoma

NCT07132528 2025-08-20

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Phase 4 Not yet recruiting

Gastrointestinal

Gastric / Gastroesophageal Junction Adenocarcinoma

NCT07127822 2025-08-17

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

Phase 2 Not yet recruiting

GastrointestinalOther solid neoplasm

Gastric / Gastroesophageal Junction Adenocarcinoma